All investigators in the field of clinical pharmacy and clinical pharmacology, ACCP members and nonmembers alike, are invited to submit abstracts to be considered for presentation during the ACCP Virtual Poster Symposium, May 17–18, 2017.
Posters will be on display May 15–18 for asynchronous viewing and comment. In addition, two interactive sessions will be scheduled on May 17 and May 18, when authors will be available for real-time online question-and-answer sessions alongside their virtual posters. The technology required for presenters and the poster-viewing audience is minimal—a broadband Internet connection, a current version of an Internet browser, and Skype (free software).
All abstracts accepted for presentation, except for “Encore” and “Research-in-Progress” presentations, will have full-text abstracts published online in Pharmacotherapy. Only the abstract title, authors, and original citation will be published in Pharmacotherapy for Encore presentations. All abstracts accepted in the Original Research category will automatically be entered in the Best Poster Award competitions.
Word Count: All abstract categories have a 300-word limit.
Submission Deadline: Friday, January 20, 2017, 11:59 p.m. (PST)
Acceptance Notification: Friday, March 31, 2017
Abstracts may be submitted in one of the following categories:
Original Research: Abstracts must summarize quantitative or qualitative findings from completed research. Basic, clinical, translational, dissemination/implementation, and educational research are examples of acceptable research. Topics should appeal to a clinical pharmacy audience and may include research in drug metabolism, education/pedagogy, health services, medication safety, patient/population outcomes, pharmacokinetics, pharmacodynamics, pharmacoeconomics, pharmacoepidemiology, pharmacogenomics, pharmacology, or pharmacotherapy. Abstracts reporting in vitro or animal research are welcome.
Systematic Reviews/Meta-analyses: Abstracts must describe a systematic review adhering to the guidelines and definitions established by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA, www.prisma-statement.org/) and must include the 12 items published in the PRISMA for Abstracts checklist (http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001419).
Case Reports: Abstracts of case reports must update and expand therapeutic insights and possibilities or generate research hypotheses. Although narrative in nature, these abstracts must stress the “evidence” for the authors’ conclusions by describing the process followed to understand the findings and possible mechanisms involved in the patient’s case, describing how the patient was evaluated and treated, and providing a specific description of the outcome.
Clinical Pharmacy Forum: Abstracts must describe the development, delivery, justification, or documentation of new or innovative clinical pharmacy services. Abstracts that address components of the ACCP Standards of Practice for Clinical Pharmacists (see www.accp.com/standards) and/or describe efforts to develop, advance, or position clinical pharmacists to optimize patient care are encouraged. Abstracts may be descriptive and need not contain an evaluative component. Encore submissions are welcome.
Advances in International Clinical Pharmacy Practice, Education, or Training: Abstracts must describe the development, delivery, justification, or documentation of clinical pharmacy practice, education, or training outside the United States. Abstracts may be descriptive and need not contain an evaluative component.
Residents and Fellows Research-in-Progress: Submission guidelines are those of an Original Research abstract except that the research effort is ongoing at the time of abstract submission.
Student Research-in-Progress: Submission guidelines are those of an Original Research abstract except that the research effort is ongoing at the time of abstract submission.
Encore Presentation: Submission and evaluation criteria are those of the Original Research, Systematic Review/Meta-analysis, Case Report, or Clinical Pharmacy Forum category, except that the same abstract was presented elsewhere or published in abstract form only before this meeting.
To obtain additional details or submit an abstract, visit www.accp.com/2017vps.